Department of Genetics, The University of Texas M.D. Anderson Cancer Center, Houston, 77030, USA.
Cold Spring Harb Perspect Biol. 2010 Apr;2(4):a001115. doi: 10.1101/cshperspect.a001115. Epub 2009 Dec 9.
Studies in mice have yielded invaluable insight into our understanding of the p53 pathway. Mouse models with activated p53, no p53, and mutant p53 have queried the role of p53 in development and tumorigenesis. In these models, p53 is activated and stabilized via redundant posttranslational modifications. On activation, p53 initiates two major responses: inhibition of proliferation (via cell-cycle arrest, quiescence, senescence, and differentiation) and induction of apoptosis. Importantly, these responses are cell-type and tumor-type-specific. The analysis of mutant p53 alleles has established a gain-of-function role for p53 mutants in metastasis. The development of additional models that can precisely time the oncogenic events in single cells will provide further insight into the evolution of tumors, the importance of the stroma, and the cooperating events that lead to disruption of the p53 pathway. Ultimately, these models should serve to study the effects of novel drugs on tumor response as well as normal homeostasis.
在小鼠中的研究为我们理解 p53 通路提供了宝贵的洞见。激活 p53、缺乏 p53 和突变 p53 的小鼠模型探究了 p53 在发育和肿瘤发生中的作用。在这些模型中,p53 通过冗余的翻译后修饰而被激活和稳定。p53 一旦被激活,就会引发两种主要反应:抑制增殖(通过细胞周期停滞、静止、衰老和分化)和诱导细胞凋亡。重要的是,这些反应具有细胞类型和肿瘤类型特异性。对突变 p53 等位基因的分析确立了 p53 突变体在转移中的功能获得作用。开发能够精确控制单细胞中致癌事件发生时间的其他模型将进一步深入了解肿瘤的演化、基质的重要性以及导致 p53 通路中断的协同事件。最终,这些模型应该有助于研究新型药物对肿瘤反应以及正常稳态的影响。